IMMUNOGEN, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 111145
 
  
 
C07K PEPTIDES 7762
 
  
 
C07D HETEROCYCLIC COMPOUNDS 62101
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 11195
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 990
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 8159
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 891
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 346
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 293
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS147

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0043,013 CYTOTOXIC AGENTS COMPRISING NEW MAYTANSINOIDS (DM4)Jun 19, 17Feb 15, 18[A61K, C07D]
2017/0348,427 PHARMACEUTICAL FORMULATIONS AND METHODS OF USE THEREOFAug 16, 17Dec 07, 17[A61K, C07K]
2017/0189,548 PHARMACEUTICAL FORMULATIONS AND METHODS OF USE THEREOFNov 23, 16Jul 06, 17[A61K, C07K]
2017/0157,264 CROSS-LINKERS AND THEIR USESOct 14, 16Jun 08, 17[A61K, C07K]
2017/0106,097 METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY MAYTANSINOID CONJUGATESJun 01, 16Apr 20, 17[A61K, A01K, C07K]
2017/0080,102 METHODS FOR CHARACTERIZING AND TREATING ACUTE MYELOID LEUKEMIAMay 19, 15Mar 23, 17[A61K, C12Q, G01N]
2017/0081,418 IMMUNOCONJUGATES TARGETING CD138 AND USES THEREOFJun 18, 16Mar 23, 17[A61K, C07K]
2017/0037,080 PREPARATION OF MAYTANSINOID ANTIBODY CONJUGATES BY A ONE-STEP PROCESSJul 21, 16Feb 09, 17[A61K, C07K]
2017/0014,522 CONJUGATES OF CYSTEINE ENGINEERED ANTIBODIESJun 28, 16Jan 19, 17[A61K, C07D, C07K]
2017/0002,393 COMPOSITIONS AND METHODS FOR ANTIBODY PRODUCTIONDec 03, 14Jan 05, 17[C12P, C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9914748 Preparation of maytansinoid antibody conjugates by a one-step processJul 21, 16Mar 13, 18[A61K, C07K]
9901647 Conjugates comprising cell-binding agents and cytotoxic agentsFeb 28, 14Feb 27, 18[A61K, C07D]
9890179 Methods of preparing cytotoxic benzodiazepine derivativesJul 21, 16Feb 13, 18[C07D, C07K]
9873708 Methods of preparing cytotoxic benzodiazepine derivativesJul 21, 16Jan 23, 18[C07D, C07K]
9868791 Methods of preparation of conjugatesApr 13, 16Jan 16, 18[A61K, C07D, C07K]
9840564 Cytotoxic benzodiazepine derivativesJul 27, 16Dec 12, 17[A61K, C07D, C07K]
9796731 Methods for the acylation of maytansinolSep 19, 16Oct 24, 17[C07D]
9789204 Process for preparing purified drug conjugatesJan 05, 15Oct 17, 17[A61K, C07K]
9771432 Conjugation methodsMay 27, 16Sep 26, 17[A61K, C07D, C07K]
9702881 Diagnostic assays and kits for detection of folate receptor 1Oct 23, 15Jul 11, 17[A61K, G01N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0183,419 NOVEL BENZODIAZEPINE DERIVATIVESAbandonedDec 07, 16Jun 29, 17[A61K, C07D, C07K]
2016/0367,698 CYTOTOXIC BENZODIAZEPINE DERIVATIVESAbandonedJun 01, 16Dec 22, 16[A61K, C07D, C07K]
2016/0115,238 CD20 Antibodies and Uses ThereofAbandonedSep 16, 15Apr 28, 16[A61K, C07K]
2016/0114,052 POTENT CONJUGATES AND HYDROPHILIC LINKERSAbandonedAug 25, 15Apr 28, 16[A61K]
2016/0108,126 CD20 Antibodies and Uses ThereofAbandonedSep 16, 15Apr 21, 16[A61K, C07K]
2016/0060,345 Novel EGFR-Binding Molecules and Immunoconjugates ThereofAbandonedAug 07, 15Mar 03, 16[C07K]
2016/0058,882 CYTOTOXIC AGENTS COMPRISING NEW ANSAMITOCIN DERIVATIVESAbandonedMay 22, 15Mar 03, 16[A61K, C07D]
2016/0017,053 Non-Antagonistic EGFR-Binding Molecules and Immunoconjugates ThereofAbandonedMay 08, 15Jan 21, 16[A61K, G01N, C07K]
2015/0343,077 Anti-CD37 Immunoconjugate Dosing RegimensAbandonedMay 12, 15Dec 03, 15[A61K, C07K]
2015/0306,242 PROCESS FOR PREPARING STABLE ANTIBODY MAYTANSINOID CONJUGATESAbandonedOct 04, 13Oct 29, 15[A61K, C07K]
2015/0297,744 Anti-FOLR1 Immunoconjugate Dosing RegimensAbandonedMar 27, 15Oct 22, 15[A61K, C07K]
2015/0110,816 METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATESAbandonedJun 04, 14Apr 23, 15[A61K, C07K]
2015/0093,397 Methods for Increasing Efficacy of CD37-Based TherapyAbandonedMar 29, 13Apr 02, 15[G01N, C07K]
2015/0071,949 CYTOTOXIC AGENTS COMPRISING NEW MAYTANSINOIDS (DM4)AbandonedAug 14, 14Mar 12, 15[A61K]
2014/0363,451 Anti-FOLR1 Immunoconjugate Dosing RegimensAbandonedMay 13, 14Dec 11, 14[A61K, C07K]
2014/0363,453 Methods for Increasing Efficacy of FOLR1 Cancer TherapyAbandonedApr 04, 14Dec 11, 14[A61K]
2014/0350,228 USE OF N-HYDROXYSUCCINIMIDE TO IMPROVE CONJUGATE STABILITYAbandonedDec 13, 12Nov 27, 14[A61K]
2014/0212,411 METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATESAbandonedSep 19, 13Jul 31, 14[A61K]
2014/0154,804 METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES AND METHODS OF MAKING SAID CONJUGATESAbandonedFeb 04, 14Jun 05, 14[C07K]
2014/0093,523 Anti-Integrin Immunoconjugates, Methods and UsesAbandonedDec 04, 13Apr 03, 14[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.